adult acute myeloid leukemia with t(8;21)(q22;q22)
Showing 51 - 75 of >10,000
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- vorinostat
- +2 more
-
Stanford, California
- +3 more
May 2, 2019
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +14 more
-
Stanford, CaliforniaStanford University Cancer Institute
Apr 1, 2019
Bone Marrow and Blood Samples in Untreated Acute Myeloid
Completed
- Leukemia
- laboratory biomarker analysis
-
San Diego, California
- +45 more
Aug 2, 2022
Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic
Completed
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- +115 more
- Fludarabine Phosphate
- +6 more
-
Denver, Colorado
- +10 more
Oct 29, 2019
Tissue and Blood Samples From Acute Myeloid Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +7 more
-
Mountain View, California
- +76 more
Aug 2, 2022
Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- Fludarabine and Busulfan
- Fludarabine and Melphalan
-
Wuhan, Hubei, ChinaWuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +17 more
- cytarabine
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019
Core Binding Factor Acute Myeloid Leukemia Trial in Guangzhou (Sorafenib, Idarubicin, Cytarabine)
Recruiting
- Core Binding Factor Acute Myeloid Leukemia
- Sorafenib
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
May 31, 2022
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
- +33 more
- therapeutic allogeneic lymphocytes
-
Stanford, CaliforniaStanford University
Mar 16, 2019
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- metformin hydrochloride
- +2 more
-
Chicago, IllinoisNorthwestern University
Jan 8, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +19 more
- umbilical cord blood transplantation
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019
Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid
Completed
- Adult Acute Erythroid Leukemia (M6)
- +15 more
- liposomal cytarabine-daunorubicin CPX-351
-
Stanford, CaliforniaStanford University, School of Medicine
Jan 17, 2019
Leukemia Trial (biological, drug, procedure, radiation)
Active, not recruiting
- Leukemia
- aldesleukin
- +9 more
- (no location specified)
Feb 17, 2022
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- sargramostim
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2022
Frequency and Risk Factors of Acute Myeloid Leukemia
Not yet recruiting
- Myeloid Leukemia
- Bone marrow aspirite for diagnosis
- (no location specified)
Mar 15, 2023
Multidrug Resistance Genes in Acute Myeloid Leukemia
Active, not recruiting
- Leukemia
- gene expression analysis
- +4 more
-
Fort Wayne, IndianaFort Wayne Medical Oncology and Hematology
Aug 16, 2021
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +14 more
- lenalidomide
- +3 more
-
Stanford, CaliforniaStanford University, School of Medicine
Oct 25, 2018
Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)
Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)
Completed
- Leukemia
- arsenic trioxide
- +4 more
-
Roseville, California
- +191 more
Dec 14, 2022
Leukemia, MDS Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- fludarabine phosphate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults, AML (Adult) With 11q23
Terminated
- Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
- +7 more
-
Stanford, CaliforniaStanford University School of Medicine
Sep 25, 2018
Leukemia, MDS Trial (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- busulfan
- +7 more
- (no location specified)
Feb 17, 2022
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent
Terminated
- B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1
- +4 more
- Dasatinib
- +3 more
-
Chicago, IllinoisNorthwestern University
Jan 31, 2020
Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional
Completed
- Acute Myeloid Leukemia
- Conventional Cytogenetics Studies
- +2 more
-
Assiut, EgyptSouth Egypt Cancer Institute
Mar 7, 2022